Yan Ming: insider trades.
Yan Ming reported 8 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.
- Transactions
- 8
- Purchases (P)
- 0
- Sales (S)
- 0
- Companies
- 1
- Name as filed
- Yan Ming
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Cytek Biosciences, Inc. (CTKB) | Director, Officer · CHIEF TECHNOLOGY OFFICER | 8 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-18 | Cytek Biosciences, Inc. | M | 7,363 | — | 4,804,051 | Form 4 |
| 2026-08-18 | Cytek Biosciences, Inc. | F | 1,778 | $4.67 | 4,802,273 | Form 4 |
| 2026-08-18 | Cytek Biosciences, Inc. | M | 5,525 | — | 4,807,798 | Form 4 |
| 2026-08-18 | Cytek Biosciences, Inc. | F | 1,346 | $4.67 | 4,806,452 | Form 4 |
| 2026-08-18 | Cytek Biosciences, Inc. | M | 6,162 | — | 4,812,614 | Form 4 |
| 2026-08-18 | Cytek Biosciences, Inc. | F | 1,501 | $4.67 | 4,811,113 | Form 4 |
| 2026-08-18 | Cytek Biosciences, Inc. | M | 14,220 | — | 4,825,333 | Form 4 |
| 2026-08-18 | Cytek Biosciences, Inc. | F | 3,463 | $4.67 | 4,821,870 | Form 4 |
Questions
What stock did Yan Ming buy or sell?
Yan Ming reported 8 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.
Is Yan Ming the same person as other filers with this name?
This page covers SEC CIK 1874041 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/yan-ming-1874041.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.